# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-039646
Filing Date
2024-10-07
Accepted
2024-10-07 08:10:19
Documents
18
Period of Report
2024-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 46441
2 |  | ex10-1.htm | EX-10.1 | 1504
3 |  | ex99-1.htm | EX-99.1 | 13197
4 |  | ex10-1_001.jpg | GRAPHIC | 365986
5 |  | ex10-1_002.jpg | GRAPHIC | 233855
6 |  | ex99-1_001.jpg | GRAPHIC | 64294
| Complete submission text file | 0001493152-24-039646.txt |  | 1158512

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | imnn-20241002.xsd | EX-101.SCH | 3009
8 | XBRL LABEL FILE | imnn-20241002_lab.xml | EX-101.LAB | 34240
9 | XBRL PRESENTATION FILE | imnn-20241002_pre.xml | EX-101.PRE | 24161
20 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3688

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 241356209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)